Oura vs Whoop vs Eight Sleep: what each one is actually good at

Three of the most-discussed consumer devices in the sleep and recovery space are Oura (a ring), Whoop (a wristband, subscription model), and Eight Sleep (a sensing mattress cover). They overlap in claims but differ in form factor, what they measure, and how well validated they are. If you've already decided a ring is the right form factor and want to weigh Oura against its ring-only rivals, see our smart ring comparison covering Galaxy Ring, RingConn and Ultrahuman.

Side-by-side comparison#

Oura ring#

What it measures: heart rate, HRV (RMSSD), skin temperature, motion, blood-oxygen estimates (newer generations).

Strengths:

• Sleep duration and resting heart rate are well-validated. Mantua et al. 2016 (four consumer wearables and a research actigraph), de Zambotti et al. 2019 (Oura ring), and subsequent independent studies show good agreement with PSG for total sleep time.
• Wrist-temperature-based cycle tracking has reasonable evidence for cycle-phase detection.
• 7-day battery life and minimal user friction.

Weaknesses:

• Sleep stage classification (light/deep/REM) shows the same accuracy limits as other consumer wearables, moderate at best vs PSG.
• Hardware cost plus an optional subscription for full features.

Whoop#

What it measures: continuous heart rate, HRV, respiratory rate, skin temperature, sleep.

Strengths:

• HRV-based "recovery score" is one of the more usable daily indicators on the market.
• Subscription model includes regular hardware refreshes.
• Strain tracking through the day is more developed than Oura's.
• Sleep coaching prompts are well-tuned.

Weaknesses:

• Wrist-based optical HR is more error-prone during certain exercises (notably weightlifting) than chest straps.
• Pure subscription model: no purchase option.
• Public validation literature is thinner than Oura's, though early data show similar sleep tracking accuracy.

Eight Sleep#

What it measures: Mattress-cover-based heart rate, HRV, respiratory rate, restlessness, surface temperature. Active feature: dual-zone temperature control.

Strengths:

• The temperature-control feature is the most differentiated. Sleep research consistently identifies bedroom and microclimate temperature as a major sleep variable; a cooled bed has direct mechanistic plausibility.
• Off-body sensing means no device on the wrist or finger; useful for people who find wearables uncomfortable.
• Couple-tracking from a single product.

Weaknesses:

• Cost is substantially higher than wearables.
• Sleep stage estimates from off-body sensing are less validated against PSG than wrist or ring devices.
• Subscription required for full feature set.

How they validate#

Most independent validation studies are device-specific and compare to PSG in laboratory settings. Common findings across the category:

• Total sleep time: generally good agreement (~10–30 min error).
• Sleep efficiency: similar.
• Stage classification: moderate at best.
• HRV during sleep: within-device night-to-night reliability is reasonable; absolute values are not comparable across devices.

Which one suits which person#

• Oura: for users who want the most validated sleep tracking with minimal friction and accept ring form factor.
• Whoop: for active users who want daily training-load and recovery feedback with active coaching.
• Eight Sleep: for users who can absorb the cost and want active intervention (temperature) rather than passive tracking.

For most users, the differences in what they measure are smaller than the differences in price and lifestyle fit.

What to actually expect#

Any of the three will give you reasonable directional information about your sleep and recovery. None of them will replace a real sleep study if you have suspected sleep apnoea, insomnia disorder, or other clinical sleep problems; these need NHS-level diagnostic work.

The wearable's value is behavioural: it makes invisible patterns (alcohol's impact on HRV, late-night training's effect on sleep) more visible. That's worth something. It's not the same as treatment.